Xtrackers Stoxx Europe 600 UCITS ETF (ETR:DX2X)
Assets | 3.07B |
Expense Ratio | 0.25% |
PE Ratio | n/a |
Dividend (ttm) | n/a |
Dividend Yield | n/a |
Ex-Dividend Date | n/a |
Payout Frequency | n/a |
Payout Ratio | n/a |
1-Year Return | +11.65% |
Volume | 1,958 |
Open | 136.62 |
Previous Close | 136.36 |
Day's Range | 136.26 - 137.16 |
52-Week Low | 119.40 |
52-Week High | 140.36 |
Beta | 1.02 |
Holdings | 655 |
Inception Date | Jan 20, 2009 |
About DX2X
Xtrackers Stoxx Europe 600 UCITS ETF is an exchange traded fund launched by Deutsche Asset & Wealth Management Investment S.A. The fund is managed by State Street Global Advisors Limited. It invests in public equity markets of Europe. The fund seeks to invest in the stocks of companies operating across diversified sectors. It invests in stocks of companies across all market capitalizations. The fund seeks to replicate the performance of STOXX Europe 600 Index, by employing representative sampling methodology. It was formerly known as db x-trackers - Stoxx Europe 600 UCITS ETF (DR). Xtrackers Stoxx Europe 600 UCITS ETF was formed on January 20, 2009 and is domiciled in Luxembourg.
Performance
DX2X had a total return of 11.65% in the past year, including dividends. Since the fund's inception, the average annual return has been 9.71%.
Top 10 Holdings
18.08% of assetsName | Symbol | Weight |
---|---|---|
SAP SE | SAP | 2.35% |
ASML Holding N.V. | ASML | 2.23% |
Nestlé S.A. | NESN | 2.14% |
Roche Holding AG | ROG | 1.73% |
Novartis AG | NOVN | 1.72% |
AstraZeneca PLC | AZN | 1.71% |
Novo Nordisk A/S | NOVO.B | 1.68% |
HSBC Holdings plc | HSBA | 1.60% |
Shell plc | SHEL | 1.53% |
Siemens Aktiengesellschaft | SIE | 1.38% |